DexCom Change in AR decreased by 217.3% to -$124.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 183.7%, from $148.90M to -$124.60M. Over 2 years (FY 2022 to FY 2024), Change in AR shows a downward trend with a -58.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease is generally positive as it indicates faster collection of cash from customers.
This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...
Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.
change_in_accounts_receivable| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | $35.70M | $30.10M | $17.00M | $4.50M | $148.30M | -$76.60M | $113.70M | $35.80M | $187.20M | $5.80M | -$33.80M | $55.60M | $7.40M | $148.90M | $184.60M | $106.20M | -$124.60M |
| QoQ Change | — | -10.8% | -15.7% | -43.5% | -73.5% | >999% | -151.7% | +248.4% | -68.5% | +422.9% | -96.9% | -682.8% | +264.5% | -86.7% | >999% | +24.0% | -42.5% | -217.3% |
| YoY Change | — | — | — | -57.5% | -87.4% | — | -354.5% | +568.8% | +695.6% | +26.2% | +107.6% | -129.7% | +55.3% | -96.0% | >999% | +646.2% | >999% | -183.7% |